Vanguard Portfolio Management
VNDA icon

Vanguard Portfolio Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Vanguard Portfolio Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92M Buy
1,131,034
+116,512
+11% +$761K ﹤0.01% 2328
2026
Q1 		$7.01M Buy
+1,014,522
New +$7.82M ﹤0.01% 2222

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management's VNDA Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Vanda Pharmaceuticals (VNDA) stake by 11% in Q2 2026, buying an estimated $761K and bringing the position to 1,131,034 shares worth $6.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Vanguard Portfolio Management first reported a position in VNDA in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.01M in Q1 2026. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Vanguard Portfolio Management held 1,131,034 shares of Vanda Pharmaceuticals worth $6.92M as of Q2 2026.
  • Vanguard Portfolio Management bought 116,512 Vanda Pharmaceuticals shares in Q2 2026, an estimated $761K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2328 holding.
  • Vanguard Portfolio Management first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Vanda Pharmaceuticals position peaked at $7.01M in Q1 2026.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.